Skip to main content

Gliga , Otilia

Institutions of which they are part

Predoctoral researcher
Headache and Neurological Pain
Vall Hebron Institut de Recerca

Gliga , Otilia

Institutions of which they are part

Predoctoral researcher
Headache and Neurological Pain
Vall Hebron Institut de Recerca

Projects

Biomarcadores neuroinflamatorios en pacientes con migraña: prueba de concepto para el diagnóstico molecular de la enfermedad

IP: Marta Vila Pueyo
Collaborators: Laila Asskour, Patricia Pozo Rosich, Victor José Gallardo Lopez, Otilia Gliga
Funding agency: Fundación Eugenio Rodríguez Pascual
Funding: 24990
Reference: FERP-2023-MVP
Duration: 17/01/2024 - 16/01/2026

X

IP: Patricia Pozo Rosich
Collaborators: Otilia Gliga, Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 89900
Reference: FI23/00149
Duration: 01/01/2024 - 31/12/2027

Related news

Two international studies led by Vall d'Hebron recommend early administration of specific drugs to prevent migraine to achieve a better response to therapy.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

The study, conducted in more than 770 people, concludes that atogepant reduces the frequency of migraine attacks and the need to take medication.

Related professionals

María José Ayala Rodas

María José Ayala Rodas

Research technician
Infectious Diseases
Read more
Judit Cabana Dominguez

Judit Cabana Dominguez

Main researcher
Psychiatry, Mental Health and Addictions
Read more
Sara Mas Assens

Sara Mas Assens

Tècnic/a Grau Superior
Secretariat for Governance and Science Policy
Internal Strategy Directorate
Read more
Mireia Leal Arranz

Mireia Leal Arranz

Administrative
Teaching Unit
Internal Strategy Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.